Epidemiology of natural immunity against COVID-19 in Benin
Open Access
- 17 January 2026
- journal article
- Published by Journal Issues Limited in International Research Journal of Public and Environmental Health
- Vol. 14 (1) , 9-17
Abstract
This study aimed to determine the national seroprevalence of natural immunity against COVID-19 in Benin and to identify factors associated with prior SARS-CoV-2 infection. A descriptive and analytical cross-sectional study was conducted between April and September 2023 across all 12 departments of Benin. A total of 3,802 participants were recruited using convenience sampling from selected health facilities, ensuring broad geographic representation of the population.Natural immunity was differentiated from vaccine-induced immunity through enzyme-linked immunosorbent assay (ELISA) testing for anti-nucleocapsid (NCP) IgG and anti-spike (S) IgG antibodies. The overall seroprevalence of natural immunity was estimated at 38.58% (95% CI: 37.0–40.1), indicating substantial exposure to SARS-CoV-2 nationwide. Despite this high seroprevalence, only 5% of participants reported a known history of COVID-19 infection, compared with approximately 10% among individuals with evidence of immunization, highlighting a large proportion of undiagnosed or asymptomatic infections.Multivariate logistic regression analysis identified several factors independently associated with natural immunity. These included increasing age (adjusted odds ratio [aOR] = 1.56; p = 0.01), residence within the former sanitary cordon (aOR = 1.34; p = 0.006), a history of hypertension or other cardiovascular diseases (aOR = 3.25; p < 0.001), and diabetes (aOR = 2.73; p < 0.001). The findings confirm significant and largely silent circulation of SARS-CoV-2 in Benin. The strong association between natural immunity and non-communicable diseases underscores the need for targeted vaccination strategies, improved risk communication, and strengthened surveillance systems, particularly for vulnerable populations in Benin and the wider West African region. Keywords: SARS-CoV-2; Natural Immunity; Seroprevalence; Comorbidities; Benin.Keywords
This publication has 17 references indexed in Scilit:
- SARS-CoV-2 seroprevalence among Beninese pregnant women in the third year of the pandemicBMC Public Health, 2024
- Population-based sero-epidemiological investigation of the dynamics of SARS-CoV-2 infections in the Greater Accra Region of GhanaScientific Reports, 2022
- Duration of immune protection of SARS-CoV-2 natural infection against reinfectionJournal of Travel Medicine, 2022
- Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studiesBMJ Open, 2021
- Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample surveyThe Lancet Global Health, 2021
- Africa’s low COVID-19 mortality rate: A paradox?International Journal of Infectious Diseases, 2021
- Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrumNature Immunology, 2020
- COVID-19: Unpacking the low number of cases in AfricaPublic Health in Practice, 2020
- COVID-19 in Africa: Dampening the storm?Science, 2020
- COVID-19 in Africa: the spread and responseNature Medicine, 2020